Peter Kelleher

8.2k total citations
96 papers, 2.9k citations indexed

About

Peter Kelleher is a scholar working on Immunology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Peter Kelleher has authored 96 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Immunology, 28 papers in Epidemiology and 25 papers in Infectious Diseases. Recurrent topics in Peter Kelleher's work include HIV Research and Treatment (16 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (11 papers). Peter Kelleher is often cited by papers focused on HIV Research and Treatment (16 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (11 papers). Peter Kelleher collaborates with scholars based in United Kingdom, United States and Australia. Peter Kelleher's co-authors include Brian Gazzard, Mark Nelson, Frances Gotch, Louise Greathead, Alan Steel, Stephen P. McAdoo, Maria Prendecki, Michelle Willicombe, Candice Clarke and Sally A. Clark and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Blood.

In The Last Decade

Peter Kelleher

94 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Kelleher United Kingdom 30 875 790 702 398 325 96 2.9k
Armin Rieger Austria 32 1.0k 1.2× 739 0.9× 1.1k 1.6× 643 1.6× 371 1.1× 123 3.6k
Manola Comar Italy 31 605 0.7× 493 0.6× 865 1.2× 403 1.0× 714 2.2× 144 3.0k
Mark Gompels United Kingdom 24 837 1.0× 351 0.4× 595 0.8× 442 1.1× 176 0.5× 89 2.7k
Joseph A. Church United States 30 826 0.9× 1.3k 1.6× 577 0.8× 808 2.0× 167 0.5× 182 3.2k
Patricia Price Australia 35 818 0.9× 1.7k 2.2× 1.8k 2.6× 1.1k 2.7× 251 0.8× 191 4.6k
Anna Nilsson Sweden 26 346 0.4× 783 1.0× 713 1.0× 441 1.1× 251 0.8× 100 2.6k
Misha Rosenbach United States 36 828 0.9× 447 0.6× 1.4k 2.0× 77 0.2× 439 1.4× 204 4.2k
Dag Kvale Norway 33 776 0.9× 1.5k 1.9× 859 1.2× 674 1.7× 279 0.9× 101 3.7k
Javier Chinen United States 23 363 0.4× 1.9k 2.4× 697 1.0× 163 0.4× 198 0.6× 64 3.2k
Marzia Duse Italy 30 416 0.5× 908 1.1× 554 0.8× 119 0.3× 107 0.3× 173 3.1k

Countries citing papers authored by Peter Kelleher

Since Specialization
Citations

This map shows the geographic impact of Peter Kelleher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Kelleher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Kelleher more than expected).

Fields of papers citing papers by Peter Kelleher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Kelleher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Kelleher. The network helps show where Peter Kelleher may publish in the future.

Co-authorship network of co-authors of Peter Kelleher

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Kelleher. A scholar is included among the top collaborators of Peter Kelleher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Kelleher. Peter Kelleher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gleeson, Sarah, Paul Martin, Tina Thomson, et al.. (2022). Comparison of Vaccine Effectiveness Against the Omicron (B.1.1.529) Variant in Hemodialysis Patients. Kidney International Reports. 7(6). 1406–1409. 25 indexed citations
2.
Thomson, Tina, Maria Prendecki, Sarah Gleeson, et al.. (2022). Immune responses following 3rd and 4th doses of heterologous and homologous COVID-19 vaccines in kidney transplant recipients. EClinicalMedicine. 53. 101642–101642. 30 indexed citations
3.
Cuthbertson, Leah, Craig Ranson, Mike Loosemore, et al.. (2022). Evidence of immunometabolic dysregulation and airway dysbiosis in athletes susceptible to respiratory illness. EBioMedicine. 79. 104024–104024. 9 indexed citations
4.
Martin, Paul, Sarah Gleeson, Candice Clarke, et al.. (2022). Comparison of immunogenicity and clinical effectiveness between BNT162b2 and ChAdOx1 SARS-CoV-2 vaccines in people with end-stage kidney disease receiving haemodialysis: A prospective, observational cohort study. The Lancet Regional Health - Europe. 21. 100478–100478. 6 indexed citations
5.
6.
Turner‐Stokes, Tabitha, Tom Cairns, Candice Clarke, et al.. (2021). Serologic Screening for Coronavirus Disease 2019 in Patients With Glomerular Disease. Kidney International Reports. 6(5). 1402–1406. 3 indexed citations
7.
Blanco, Jesús Miguéns, Federica Borghese, Neil McHugh, et al.. (2020). Longitudinal profiling of the gut microbiome in patients with psoriatic arthritis and ankylosing spondylitis: a multicentre, prospective, observational study. BMC Rheumatology. 4(1). 60–60. 2 indexed citations
8.
Prendecki, Maria, Candice Clarke, Sarah Gleeson, et al.. (2020). Detection of SARS-CoV-2 Antibodies in Kidney Transplant Recipients. Journal of the American Society of Nephrology. 31(12). 2753–2756. 25 indexed citations
9.
10.
Rezvani, Katayoun, et al.. (2018). Human NK Cells Develop an Exhaustion Phenotype During Polar Degranulation at the Aspergillus fumigatus Hyphal Synapse. Frontiers in Immunology. 9. 2344–2344. 11 indexed citations
11.
Cowman, Steven, Joseph Jacob, David M. Hansell, et al.. (2017). Whole-Blood Gene Expression in Pulmonary Nontuberculous Mycobacterial Infection. American Journal of Respiratory Cell and Molecular Biology. 58(4). 510–518. 32 indexed citations
12.
Bamford, Alasdair, Peter Kelleher, Hermione Lyall, et al.. (2014). Serological response to 13-valent pneumococcal conjugate vaccine in children and adolescents with perinatally acquired HIV infection. AIDS. 28(14). 2033–2043. 18 indexed citations
13.
Pantelidis, Panagiotis, Neil Soni, Masao Takata, et al.. (2014). A Biomarker Panel (Bioscore) Incorporating Monocytic Surface and Soluble TREM-1 Has High Discriminative Value for Ventilator-Associated Pneumonia: A Prospective Observational Study. PLoS ONE. 9(10). e109686–e109686. 39 indexed citations
14.
Clark, Sally A., Emma Page, Tom Ford, et al.. (2011). Reduced TH1/TH17 CD4 T-cell numbers are associated with impaired purified protein derivative–specific cytokine responses in patients with HIV-1 infection. Journal of Allergy and Clinical Immunology. 128(4). 838–846.e5. 12 indexed citations
15.
Beirne, Paul, P. Pantelidis, P. Charles, et al.. (2009). Multiplex immune serum biomarker profiling in sarcoidosis and systemic sclerosis. European Respiratory Journal. 34(6). 1376–1382. 55 indexed citations
16.
17.
Kelleher, Peter, et al.. (2002). What is Good’s syndrome? Immunological abnormalities in patients with thymoma. Journal of Clinical Pathology. 56(1). 12–16. 185 indexed citations
18.
Kelleher, Peter, Asher Maroof, & Stella C. Knight. (1999). Retrovirally induced switch from production of IL-12 to IL-4 in dendritic cells. European Journal of Immunology. 29(7). 2309–2318. 4 indexed citations
19.
Kelleher, Peter. (1998). IL-12 increases CD80 expression and the stimulatory capacity of bone marrow-derived dendritic cells. International Immunology. 10(6). 749–755. 54 indexed citations
20.
Watts, Gerald F., et al.. (1992). A cross-cultural assessment of perceived health problems in the elderly. Disability and Rehabilitation. 14(3). 133–135. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Armin Rieger Breakdown of academic impact, for papers by Manola Comar Breakdown of academic impact, for papers by Mark Gompels Breakdown of academic impact, for papers by Joseph A. Church Breakdown of academic impact, for papers by Patricia Price Breakdown of academic impact, for papers by Anna Nilsson Breakdown of academic impact, for papers by Misha Rosenbach Breakdown of academic impact, for papers by Dag Kvale Breakdown of academic impact, for papers by Javier Chinen Breakdown of academic impact, for papers by Marzia Duse
Rankless by CCL
2026